Asset Class
Equities Research Hub
Global equity markets are currently navigating a 'risk-off' environment characterized by a significant rotation from technology to defensive sectors. This shift is highlighted by a sharp 5.9% decline in the US Momentum factor and a correction in US tech stocks, even as companies like Alphabet continue massive investments in AI infrastructure. Earnings reports for 4Q25 reveal a mixed landscape; while consumer names like Yum! Brands show resilience, sector-specific pressures such as multiple compression for Ferrari and disappointing guidance from Information Services firm Gartner have led to price target downward revisions. In Europe, pharmaceutical giants GSK and Novartis have issued guidance trailing consensus, further contributing to a cautious outlook in the region. Regional equity sentiment is also being shaped by political developments, most notably in Japan, where a projected LDP victory is expected to support 'Abenomics'-style stimulus alongside Bank of Japan rate hikes totaling 75bp. Additionally, the cooling of Brent crude prices toward $68/b amid diplomatic progress in the Middle East and large-scale renewable energy investments, such as Saudi Arabia's $2bn solar agreement with Turkey, are influencing broader market dynamics. Despite localized volatility and currency fluctuations, global PMIs suggest an underlying 2.8% annualized rise in GDP, providing a macro cushion for diversified equity portfolios.
4233 reports available
All reports
Page 105 of 177
When Rates Stop Helping Stocks
The Market Ear · May 28, 2026
Kohl's First Take: Comp Trends Slightly Stronger
Goldman Sachs · May 28, 2026
The Point for CEEMEA
Citi · May 28, 2026
Brazil Homebuilders: Lunch with Construtora Lindenberg
Goldman Sachs · May 28, 2026
Feedback From Dbaccess European Champions Conference
Deutsche Bank · May 28, 2026
Lowering Estimates Post Soft 1Q26 Results
Goldman Sachs · May 28, 2026
Stalled US-Iran Talks Should Not Derail Solid Fundamentals
UBS · May 28, 2026
Commodities Tracker
Global X by Mirae Asset · May 28, 2026
Pfizer Sig Vedotin Trial Protocol Amendment
Goldman Sachs · May 28, 2026
AI On Steroids
The Market Ear · May 28, 2026
Brazil Banks April SCR Data Analysis
Goldman Sachs · May 28, 2026
ASCO 2026 Preview for China Pharma and Biotech Takeaways from Abstracts
Goldman Sachs · May 28, 2026
China Resources Beer NDR Highlights
Goldman Sachs · May 28, 2026
China Smartphones April Shipments and Camera Trends
Goldman Sachs · May 28, 2026
Dick's Sporting Goods 1Q26 Results First Take
Goldman Sachs · May 28, 2026
Life Healthcare Group 1H26 First Take
Goldman Sachs · May 28, 2026
US Morning Call
Goldman Sachs · May 28, 2026
Gold Can Regain Momentum as Tightening Fears Fade
UBS · May 28, 2026
How Major Sport Events Drive Consumer Sectors
UBS · May 28, 2026
Emerging Market Equities Brazil Downgrade
UBS · May 28, 2026
Leading Index Bulletin
Westpac Banking Corporation · May 28, 2026
After the Energy Shock
FTSE Russell · May 28, 2026
Gold Can Regain Momentum as Tightening Fears Fade
UBS · May 28, 2026
Investing in China: Steadier Ties Stronger Fundamentals
UBS · May 28, 2026